Big pharma drama: Genmab and AbbVie’s blood cancer drug, epcoritamab, just flopped in a major late-stage trial. While some patients saw their cancer disappear, the drug didn’t actually help people live longer. Shares dropped fast, and now the companies are scrambling to figure out what’s next. More trial results are coming in 2026—fingers crossed for better news then! #Health #BodyHealth #CancerResearch